Phase II evaluation of aclarubicin in refractory adult acute leukemia: a Southwest Oncology Group Study. (Q33452126)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II evaluation of aclarubicin in refractory adult acute leukemia: a Southwest Oncology Group Study. |
scientific article |
Statements
Phase II evaluation of aclarubicin in refractory adult acute leukemia: a Southwest Oncology Group Study (English)
Dabich L
Bull FE
Beltran G
Athens JW
Coltman CA Jr
Weick JK
Van Slyck EJ
1 August 1986